Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
66.6M
-
Number of holders
-
362
-
Total 13F shares, excl. options
-
59.5M
-
Shares change
-
-959K
-
Total reported value, excl. options
-
$6.92B
-
Value change
-
-$142M
-
Put/Call ratio
-
0.44
-
Number of buys
-
203
-
Number of sells
-
-176
-
Price
-
$116.29
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q1 2022
446 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q1 2022.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 362 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59.5M shares
of 66.6M outstanding shares and own 89.35% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.53M shares), VANGUARD GROUP INC (6.31M shares), FMR LLC (6.12M shares), Capital World Investors (2.85M shares), Invesco Ltd. (2.08M shares), STATE STREET CORP (1.71M shares), Champlain Investment Partners, LLC (1.54M shares), Jackson Square Partners, LLC (1.5M shares), BROWN CAPITAL MANAGEMENT LLC (1.22M shares), and FEDERATED HERMES, INC. (1.2M shares).
This table shows the top 362 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.